Human Kidney Multimodal Single Cell and Spatial Transcriptomics Atlas Identify Key Cell Types and Pathways for Diabetic Kidney Disease
作者
Amin Abedini,Ziyuan Ma,Julia Frederick,Kishor B. Devalaraja-Narashimha,Lori G. Morton,Gurmannat Kalra,Erding Hu,Lea Sarov‐Blat,Carine Boustany,Paolo Guarnieri,John Thomas Liles,Anil K. Karihaloo,Hanying Yan,Kyle P. Coleman,Jian Hu,Qihuang Zhang,Matthew Palmer,Mingyao Li,Katalin Suszták
Background: Diabetic kidney disease (DKD) is responsible for more than half of all end stage renal disease in the US, yet disease driving cell types and pathways are poorly defined. Innovative single cell tools can define transcriptomics, gene regulation or even spatial gene expression at single cell resolution. Methods: We generated single cell and single nuclear gene expression (scRNA-seq, snRNA-seq) and single nuclear assay of open chromatin (snATAC-seq) datasets for 66 (34 healthy and 32 CKD/DKD) samples capturing 0.5 million cells. Furthermore, we generated high-quality spatial gene expression datasets for healthy and DKD kidneys. The data was complemented with bulk RNA-seq, clinical and histological information available for 298 human kidney samples. Results: Our high-quality kidney single cell atlas captured 40 main and more than 100 cell subtypes or cell states, including epithelial, endothelial, immune and stromal cells. Using a combination of snRNA and spatial transcriptomics analyses, we successfully mapped all cell types and states back to their spatial location in healthy and diseased kidneys. Our results highlighted the key role of proximal tubule, immune, and stromal cells in disease development. We identified different localization patterns of different cell types, including a novel interaction between stromal, immune cells and injured tubule cells in fibrosis. Our analyses defined a gene signature pattern for injury niches, which could also accurately classify a cohort of 298 tubule bulk RNA-seq into subsets based on eGFR and renal fibrosis. Conclusions: Our comprehensive human kidney single cell and spatial atlas define new pathways and gene signatures for DKD, and a valuable resource for the community to identify potential new therapeutic targets, pathways and cell types in kidney diseases. Funding: Commercial Support - GSK, Regeneron, Boehringer, Gilead, Novo Nordisk